{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:25Z","timestamp":1790270905436,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:00:00Z","timestamp":1310688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Activation of the oxidative burst and failure of CD4+CD25+ cell regulation have been implicated in idiopathic nephrotic syndrome (iNS). The intimate mechanism is, however, unknown and requires specifically focused studies. We investigated reactive oxygen species (ROS) generation [di-chlorofluorescein-diacetate (DCFDA)] fluorescence assay and the regulatory adenosine 5\u2032-triphosphate (ATP) pathways in the blood of 41 children with iNS, utilizing several agonists and antagonists of nucleotide\/nucleoside receptors, including the addition of soluble apyrase. The CD4+CD25+CD39+\/CD73+ expression was determined in vivo in parallel during disease activity. Overall, we found that the percentage of CD39+CD4+CD25+ was reduced markedly in iNS by 80% (3\u00b743\u2003\u00b1\u20030\u00b704% versus 13\u00b714\u2003\u00b1\u20030\u00b707% of total lymphocytes, P\u2003&amp;lt;\u20030\u00b7001). In these patients, reactive oxygen species (ROS) generation by polymorphonuclear neutrophils (PMN) at rest was a function of apyrase (CD39) expressed by CD4+CD25+, with higher rates in patients with very low CD39+CD4+CD25+ levels (&amp;lt;\u20037\u00b75%). Addition of apyrase reduced ROS generation by 40% in both iNS and controls and was mainly effective in patients. The quota of ROS surviving ATP elimination was higher still in iNS. In vitro studies to limit ROS generation with adenosine analogues (2\u2032-chloroadenosine and 5\u2032-N-ethylcarboxamidoadenosine) produced minor effects. At variance, antagonizing ATP efflux with carbenoxolone or by antagonizing ATP effects (Brilliant Blue G, KN62 and A437089) reduced ROS generation comparable to apyrase. These results confirm a key role of ATP in the regulation of innate immunity and minimize the effect of adenosine. Decreased CD39+CD4+CD25+ expression in iNS highlights an impairment of ATP degradation in this pathology. However, high ROS surviving ATP consumption implies a major role of other regulatory pathways.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04441.x","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T14:20:59Z","timestamp":1310739659000},"page":"55-63","source":"Crossref","is-referenced-by-count":25,"title":["Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome"],"prefix":"10.1093","volume":"166","author":[{"given":"R","family":"Bertelli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Dialysis, Transplantation and Laboratory on Pathophysiology of Uremia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bodria","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Dialysis, Transplantation and Laboratory on Pathophysiology of Uremia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nobile","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, National Research Council (CNR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Alloisio","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, National Research Council (CNR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, National Research Council (CNR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Montobbio","sequence":"additional","affiliation":[{"name":"Division of Anesthesiology, Istituto Giannina Gaslini IRCCS, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Patrone","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G M","family":"Ghiggeri","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Dialysis, Transplantation and Laboratory on Pathophysiology of Uremia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,15]]},"reference":[{"key":"2021122708463655700_b1","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1681\/ASN.V12122742","article-title":"Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis","volume":"12","author":"Caridi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2021122708463655700_b2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.ASN.0000060578.79050.E0","article-title":"Broadening the spectrum of diseases related to podocin mutations","volume":"14","author":"Caridi","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021122708463655700_b3","doi-asserted-by":"crossref","first-page":"54R","DOI":"10.1203\/01.PDR.0000160446.01907.B1","article-title":"NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms","volume":"57","author":"Caridi","year":"2005","journal-title":"Pediatr Res"},{"key":"2021122708463655700_b4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00467-008-1051-3","article-title":"Familial forms of nephrotic syndrome","volume":"25","author":"Caridi","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"2021122708463655700_b5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(75)91164-2","article-title":"Lymphokines and nephrotic syndrome [Letter]","volume":"1","author":"Lagrue","year":"1975","journal-title":"Lancet"},{"key":"2021122708463655700_b6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"2021122708463655700_b7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/ndt\/16.5.882","article-title":"Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor","volume":"16","author":"Ghiggeri","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708463655700_b8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"2021122708463655700_b9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2010.04160.x","article-title":"Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome","volume":"161","author":"Bertelli","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122708463655700_b10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00859620","article-title":"Peroxidative damage of the erythrocyte membrane in children with nephrotic syndrome","volume":"3","author":"Ginevri","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"2021122708463655700_b11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1681\/ASN.2006090965","article-title":"Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin","volume":"18","author":"Musante","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021122708463655700_b12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jprot.2009.06.006","article-title":"The oxido-redox potential of albumin methodological approach and relevance to human diseases","volume":"73","author":"Candiano","year":"2009","journal-title":"J Proteomics"},{"key":"2021122708463655700_b13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/ki.2009.322","article-title":"Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms","volume":"76","author":"Zhou","year":"2009","journal-title":"Kidney Int"},{"key":"2021122708463655700_b14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db08-0057","article-title":"Oxidative stress as a major culprit in kidney disease in diabetes","volume":"57","author":"Forbes","year":"2008","journal-title":"Diabetes"},{"key":"2021122708463655700_b15","first-page":"16","article-title":"Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events","volume":"46","author":"Bertani","year":"1982","journal-title":"Lab Invest"},{"key":"2021122708463655700_b16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0272-6386(86)80051-8","article-title":"Adriamycin-induced glomerulosclerosis in the rat","volume":"7","author":"Bertani","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"2021122708463655700_b17","doi-asserted-by":"crossref","first-page":"26734","DOI":"10.1074\/jbc.272.42.26734","article-title":"Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome","volume":"272","author":"Raats","year":"1997","journal-title":"J Biol Chem"},{"key":"2021122708463655700_b18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/BF02631246","article-title":"Cytotoxic effect of adriamycin and agarose-coupled adriamycin on glomerular epithelial cells: role of free radicals","volume":"27A","author":"Bertelli","year":"1991","journal-title":"In Vitro Cell Dev Biol"},{"key":"2021122708463655700_b19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0780283","article-title":"Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis","volume":"78","author":"Ginevri","year":"1990","journal-title":"Clin Sci"},{"key":"2021122708463655700_b20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ndt\/gfg564","article-title":"Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis","volume":"19","author":"Lebrecht","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708463655700_b21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.1991.176","article-title":"Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro","volume":"40","author":"Ghiggeri","year":"1991","journal-title":"Kidney Int"},{"key":"2021122708463655700_b22","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708463655700_b23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1681\/ASN.2006050500","article-title":"Oxidants in chronic kidney disease","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021122708463655700_b24","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1681\/ASN.2006080833","article-title":"COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement","volume":"18","author":"Diomedi-Camassei","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021122708463655700_b25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11302-006-9038-7","article-title":"Extracellular NAD and ATP: partners in immune cell modulation","volume":"3","author":"Haag","year":"2007","journal-title":"Purinergic Signal"},{"key":"2021122708463655700_b26","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.freeradbiomed.2007.02.010","article-title":"Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation","volume":"42","author":"Pfeiffer","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"2021122708463655700_b27","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.4049\/jimmunol.166.11.6754","article-title":"P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils","volume":"166","author":"Suh","year":"2001","journal-title":"J Immunol"},{"key":"2021122708463655700_b28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"key":"2021122708463655700_b29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-6147(00)01574-1","article-title":"P2 receptors meet the immune system","volume":"22","author":"Di Virgilio","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"2021122708463655700_b30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-006-9048-5","article-title":"Purinergic signalling in the immune system. A brief update","volume":"3","author":"Di Virgilio","year":"2007","journal-title":"Purinergic Signal"},{"key":"2021122708463655700_b31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","article-title":"Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin","volume":"41","author":"Bertelli","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2021122708463655700_b32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0076-6879(86)33055-6","article-title":"Commercially available firefly luciferase reagents","volume":"133","author":"Leach","year":"1986","journal-title":"Methods Enzymol"},{"key":"2021122708463655700_b33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1172\/JCI36433","article-title":"Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39","volume":"119","author":"Hyman","year":"2009","journal-title":"J Clin Invest"},{"key":"2021122708463655700_b34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal"},{"key":"2021122708463655700_b35","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708463655700_b36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"2021122708463655700_b37","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"2021122708463655700_b38","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2010.03291.x","article-title":"Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype","volume":"10","author":"Dwyer","year":"2010","journal-title":"Am J Transplant"},{"key":"2021122708463655700_b39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(03)00086-X","article-title":"Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes","volume":"331","author":"Walrand","year":"2003","journal-title":"Clin Chim Acta"},{"key":"2021122708463655700_b40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2009.05.005","article-title":"Adenosine: an endogenous modulator of innate immune system with therapeutic potential","volume":"616","author":"Kumar","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"2021122708463655700_b41","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.bmc.2007.01.055","article-title":"6)-[(hetero)aryl\/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5\u2032-N- ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor","volume":"15","author":"Baraldi","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"2021122708463655700_b42","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.0902531106","article-title":"Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury","volume":"106","author":"Peng","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708463655700_b43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/mol.58.1.82","article-title":"Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors","volume":"58","author":"Jiang","year":"2000","journal-title":"Mol Pharmacol"},{"key":"2021122708463655700_b44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bjp.0707196","article-title":"Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding","volume":"151","author":"Michel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"2021122708463655700_b45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","article-title":"Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states","volume":"151","author":"Donnelly-Roberts","year":"2007","journal-title":"Br J Pharmacol"},{"key":"2021122708463655700_b46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4161\/chan.3.5.9568","article-title":"Carbenoxolone inhibits volume-regulated anion conductance in cultured rat cortical astroglia","volume":"3","author":"Benfenati","year":"2009","journal-title":"Channels"},{"key":"2021122708463655700_b47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0891-5849(00)00495-0","article-title":"Relative reactivities of N-chloramines and hypochlorous acid with human plasma constituents","volume":"30","author":"Carr","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"2021122708463655700_b48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mas.20006","article-title":"Proteins as biomarkers of oxidative\/nitrosative stress in diseases: the contribution of redox proteomics","volume":"24","author":"Dalle-Donne","year":"2005","journal-title":"Mass Spectrom Rev"},{"key":"2021122708463655700_b49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11302-006-9035-x","article-title":"Nucleotide receptor signalling and the generation of reactive oxygen species","volume":"3","author":"Guerra","year":"2007","journal-title":"Purinergic Signal"},{"key":"2021122708463655700_b50","doi-asserted-by":"crossref","first-page":"8410","DOI":"10.4049\/jimmunol.180.12.8410","article-title":"A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes","volume":"180","author":"Hewinson","year":"2008","journal-title":"J Immunol"},{"key":"2021122708463655700_b51","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1038\/bjp.2008.23","article-title":"Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells","volume":"153","author":"Sitkovsky","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2021122708463655700_b52","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2006.08.079","article-title":"Characterization of oxidation end product of plasma albumin in vivo","volume":"349","author":"Musante","year":"2006","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04441.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/166\/1\/55\/41909046\/j.1365-2249.2011.04441.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/166\/1\/55\/41909046\/j.1365-2249.2011.04441.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:28:04Z","timestamp":1686198484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/166\/1\/55\/6422879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,7,15]]},"published-print":{"date-parts":[[2011,9,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04441.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,7,15]]}}}